KIT and chronic granulomatous disease: HSPC-depleting mAb as the anti-CD117 ACK2 (c-kit antagonist) allowed increased chimerism in Rag2-/-γc-/- mice, but not in immunocompetent mice (50) and X-linked chronic granulomatous disease (X-CGD) mice (51).